Gregory Everson
Company: HepQuant
Job title: Founder & Chief Executive Officer
Seminars:
Next Generation Liver Function Testing for Drug Development and the Clinic 11:00 am
Utility in clinical trials Improvements in test administration Relationship to outcomesRead more
day: Seminar B- AM tracks
Chair’s Opening Remarks 9:25 am
day: Seminar B- AM tracks
Reimagining Non-Invasive Biomarkers for Improved Clinical Outcome to Move the Needle on Validation
Seminar Moderators: 9:24 am
Seminar Moderators:
day: Seminar B- AM tracks